耐糖能異常を伴う高血圧患者におけるバルサルタンとアムロジピンの比較

基本情報

NCT ID

NCT00129233

ステータス

完了

試験のフェーズ

第4相

試験タイプ

介入

目標被験者数

1,150

治験依頼者名

Nagoya University

概要

Various guidelines recommended angiotensin converting enzyme (ACE) inhibitors or angiotensin Ⅱ receptor-1 blockers (ARBs) for hypertensive patients with diabetes on the basis of the cardiac- and reno-protective effects of these drugs. However, these recommendations could not be extrapolated to Japanese patients, because Japan has been known as a country with a low incidence of coronary artery disease and a high incidence of cerebrovascular disease. Furthermore, calcium channel blockers (CCBs) also were protective against renal function as well as ACE inhibitors in Japanese diabetic hypertensive patients. This study will test whether ARBs or CCBs are superior in treating Japanese diabetic hypertensive patients.

対象疾患

介入

依頼者（Sponsor）

実施施設 (1)